Inhibition of human cytomegalovirus major capsid protein expression and replication by ribonuclease P-associated external guide sequences

RNA
Qiudi DengFenyong Liu

Abstract

External guide sequences (EGSs) signify the short RNAs that induce ribonuclease P (RNase P), an enzyme responsible for processing the 5' termini of tRNA, to specifically cleave a target mRNA by forming a precursor tRNA-like complex. Hence, the EGS technology may serve as a potential strategy for gene-targeting therapy. Our previous studies have revealed that engineered EGS variants induced RNase P to efficiently hydrolyze target mRNAs. In the present research, an EGS variant was designed to be complementary to the mRNA coding for human cytomegalovirus (HCMV) major capsid protein (MCP), which is vital to form the viral capsid. In vitro, the EGS variant was about 80-fold more efficient in inducing human RNase P-mediated cleavage of the target mRNA than a natural tRNA-derived EGS. Moreover, the expressed variant and natural tRNA-originated EGSs led to a decrease of MCP expression by 98% and 73%-74% and a decrease of viral growth by about 10,000- and 200-fold in cells infected with HCMV, respectively. These results reveal direct evidence that the engineered EGS variant has higher efficiency in blocking the expression of HCMV genes and viral growth than the natural tRNA-originated EGS. Therefore, our findings imply that the EGS vari...Continue Reading

References

Dec 1, 1992·Scientific American·G F Joyce
Feb 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W L Drew
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y YuanS Altman
Mar 1, 1992·Trends in Biochemical Sciences·J W Szostak
Aug 17, 1990·Science·A C Forster, S Altman
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A M PyleT R Cech
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·C Guerrier-TakadaS Altman
Jan 1, 1995·Annual Review of Biochemistry·L GoldM Yarus
Sep 1, 1994·Journal of Virology·L Matusick-KumarM Gao
Jan 1, 1996·Intervirology·W Gibson
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·D Plehn-Dujowich, S Altman
Dec 14, 2001·The Journal of Biological Chemistry·Venkat GopalanSidney Altman
Jun 28, 2002·Nature·Jean-Marc JacqueMario Stevenson
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Dong YuThomas Shenk
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Walter DunnFenyong Liu
Dec 4, 2003·Nature Biotechnology·Lisa J Scherer, John J Rossi
Jan 14, 2004·The Journal of General Virology·Lüder WiebuschChristian Hagemeier
Jun 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jiaming ZhuFenyong Liu
May 9, 2006·Trends in Biochemical Sciences·Donald EvansNorman R Pace
Oct 30, 2008·Nucleic Acids Research·Frank JühlingJoern Pütz
Oct 22, 2009·Journal of Cellular Biochemistry·Michael C Marvin, David R Engelke
Apr 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yong BaiFenyong Liu
Mar 14, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chuan XiaFenyong Liu
Nov 29, 2014·Science·Jennifer A Doudna, Emmanuelle Charpentier
Oct 5, 2017·Nature·Omar O AbudayyehFeng Zhang

❮ Previous
Next ❯

Citations

Feb 23, 2020·International Journal of Molecular Sciences·Shao-Cheng WangYuan-Chuan Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.